Many people who experienced serious side effects from using popular GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Trulicity, have sued the manufacturers in mass tort litigation
Gonzlez-Garca, I., Gruber, T
F., Karevicius, S., Malsch, M., Sarda, V., Fadayomi, A., Harris, H
You could call L cells a GLP-1 factory. The major difference between the GLP-1 you take via medication versus that in food is how long it lasts in the body
We know that for these patients with obesity, diabetes, CKD, cardiovascular disease [CVD], these are really not isolated or distinct entities. However, the research comes at a time when supply chain issues for the GLP-1 receptor agonists have been pronounced and prolonged
Eligibility, continuation, or discontinuation of GLP1 treatment is determined independently by licensed clinicians based on medical evaluation, not by celebrity outcomes or platform access